کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
3462724 | 1231512 | 2011 | 6 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Oversight and management of a cell therapy clinical trial network: Experience and lessons learned
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
موضوعات مرتبط
علوم پزشکی و سلامت
پزشکی و دندانپزشکی
پزشکی و دندانپزشکی (عمومی)
پیش نمایش صفحه اول مقاله
![عکس صفحه اول مقاله: Oversight and management of a cell therapy clinical trial network: Experience and lessons learned Oversight and management of a cell therapy clinical trial network: Experience and lessons learned](/preview/png/3462724.png)
چکیده انگلیسی
The Cardiovascular Cell Therapy Research Network (CCTRN), sponsored by the National Heart, Lung, and Blood Institute (NHLBI), was established to develop, coordinate, and conduct multiple collaborative protocols testing the effects of cell therapy on cardiovascular diseases. The Network was born into a difficult political and ethical climate created by the recent removal of a dozen drugs from the US formulary and the temporary halting of 27 gene therapy trials due to safety concerns. This article describes the Network's challenges as it initiated three protocols in a polarized cultural atmosphere at a time when oversight bodies were positioning themselves for the tightest vigilance of promising new therapies. Effective strategies involving ongoing education, open communication, and relationship building with the oversight community are discussed.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Contemporary Clinical Trials - Volume 32, Issue 5, September 2011, Pages 614-619
Journal: Contemporary Clinical Trials - Volume 32, Issue 5, September 2011, Pages 614-619
نویسندگان
Lemuel A. Moyé, Shelly L. Sayre, Lynette Westbrook, Beth C. Jorgenson, Eileen Handberg, Saif Anwaruddin, Kristi A. Wagner, Sonia I. Skarlatos,